newsfilter
← Latest News
GlobeNewswire·

Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board